St. Jude Medical Inc. on Monday said third-quarter profit rose 84%, boosted by strong sales of implantable heart devices, a day after the company announced a $1.3 billion deal to expand into products to treat pain and nervous system disorders.
*For more on this story,
read the full Reuters article.
